ATHENS — Prime Minister Kyriakos Mitsotakis met on Friday with the CEO of the multinational pharmaceutical company Boehringer Ingelheim, Hubertus von Baumbach, as well as the Global head of HP and member of the board, Carinne Brouillon, the director of the MIDI region – which includes Greece – and the general director of the company in Greece, Dimitris Anagnostakis.

According to government sources, the company has been active in Greece since 1966, is developing innovative products for cardio and oncologic diseases, diabetes, respiratory diseases as well as rare diseases. They also said that the company's plant in Koropi is one of the company's four strategically important factories worldwide and has 545 employees.

The same sources said that Mitsotakis thanked Von Baumbach for the 80 million euros investments made by the company during the period of the crisis in Greece, from 2008 until the present day, and discussed the prospect of a new round of investments amounting to another 80 million euros in the next five years.

Mitsotakis also presented the new investment incentives for pharmaceutical industries in Greece in terms of investments in clinical research, as well as innovative products regarding investments in capital equipment and underlined the importance the Greek government gives to attracting and the permanent settlement of talented professionals in Greece, via the reduction of non-salary costs.